menu
    • menu

    Company profile for Coherus Biosciences

    NEW Drugs in Dev: 19
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Coherus Bioscience is a leading developer of high-quality biosimilar therapeutics. Our team is comprised of successful veterans who helped pioneer the biologic industry. We have all joined together and are driven by a common mission: improving patient benefit by expanding access to biologic drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Coherus BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    333 Twin Dolphin Drive Suite 600 Redwood City, CA 94065
    Telephone
    Telephone
    1 800-794-5434
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.coherus.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/coherus-biosciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/coherus_bio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Coherus Oncology Unveils Q1 2026 Financials And Business Update
    Coherus Oncology Unveils Q1 2026 Financials And Business Update

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292299/33333/en/coherus-oncology-reports-first-quarter-2026-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Coherus Oncology to Report Q1 2026 Results on May 11
    Coherus Oncology to Report Q1 2026 Results on May 11

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286820/33333/en/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Coherus & Storm therapeutics to Test STC-15 + LOQTORZI in Combo
    Coherus & Storm therapeutics to Test STC-15 + LOQTORZI in Combo

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088627/33333/en/Coherus-Announces-Clinical-Collaboration-with-STORM-Therapeutics-to-Evaluate-STC-15-in-Combination-with-LOQTORZI-toripalimab-tpzi.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Coherus BioSciences Reports Q1 2025 Results and Business Update
    Coherus BioSciences Reports Q1 2025 Results and Business Update

    12 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/12/3079578/33333/en/Coherus-BioSciences-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 May 2025
    Share Share
    Coherus to Report Q1 2025 Financial Results on May 12, 2025
    Coherus to Report Q1 2025 Financial Results on May 12, 2025

    05 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/05/3074482/33333/en/Coherus-to-Report-First-Quarter-2025-Financial-Results-on-May-12-2025.html

    GLOBENEWSWIRE
    05 May 2025
    Share Share
    Coherus to Participate in Upcoming Investor Conferences
    Coherus to Participate in Upcoming Investor Conferences

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072917/33333/en/Coherus-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search